During the past decade, TidalHealth Nanticoke / Allen Cancer Center conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 32 clinical trials were completed, i.e. on average, 42.7% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 27 clinical trials were completed. i.e. 93.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TidalHealth Nanticoke / Allen Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 65 trials, followed by "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TidalHealth Nanticoke / Allen Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "TidalHealth Nanticoke / Allen Cancer Center" are "Invasive Breast Carcinoma" (8 trials), "Recurrent Breast Carcinoma" (6 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials) and "Recurrent Ovarian Carcinoma" (4 trials). Many other conditions were trialed in "TidalHealth Nanticoke / Allen Cancer Center" in a lesser frequency.

Most popular intervention types in "TidalHealth Nanticoke / Allen Cancer Center" are "Drug" (79 trials), "Other" (66 trials), "Biological" (46 trials), "Procedure" (30 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (31 trials), "Biospecimen Collection" (16 trials), "Carboplatin" (16 trials) and "Computed Tomography" (16 trials). Other intervention names were less common.

The vast majority of trials in "TidalHealth Nanticoke / Allen Cancer Center" are 80 trials for "All" genders, 19 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "TidalHealth Nanticoke / Allen Cancer Center". undefined are not yet recruiting, 29 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in TidalHealth Nanticoke / Allen Cancer Center, 4 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in TidalHealth Nanticoke / Allen Cancer Center, 1 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".